Search Results 21-30 of 16623 for GLP-1 alternatives

  1. Bariatric Surgery Clinical Trials - Mayo Clinic Research

    A Study To Determine The Effect Of Endogenous Glucagon-Like Peptide ... GLP-1 is less marked. In this study the ... Ketamine is an alternative pain medicine that ...

  2. Preoperative Gastric Content With Ultrasound Assessment in Patients Taking GLP1 Agonists - Mayo Clinic

    ... glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists. Participation eligibility. Participant eligibility ...

  3. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

    ... GLP1 Agonist and GLP-1/ GIP agonist medications. Print details. Share ... It is proposed that participants will wear the devices for a period of 28 days before ...

  4. Yerba mate: Is it safe to drink? - Mayo Clinic

    Type 3 or more letters to display suggested search options ... The higher risk is linked with drinking about 1 ... See also. 10 great health foods · Alcohol use: ...

  5. Islet GLP-1 in Prediabetes - Clinical Trials

    The purpose of this study is to determine the contribution of islet GLP-1 to islet function in prediabetes. Participation eligibility. Participant ...

  6. Tirzepatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is ...

  7. Tradipitant After GLP-1R Agonist In Healthy, Overweight, or Class I or II Obese Volunteers - Mayo Clinic

    The purpose of this study is to evaluate the effect of tradipitant relative to placebo on proportion of subjects with at least 1 vomiting episode per week ...

  8. Examining the impact of GLP-1 receptor agonist use on quality of bowel preparation for colonoscopy - Mayo Clinic

    Type 3 or more letters to display suggested search options. ... Examining the impact of GLP-1 ... The rapidly rising use of glucagon-like peptide-1 (GLP-1) ...

  9. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    Type 3 or more letters to display suggested search options. ... Incretin-modifying agents, including glucagon-like peptide-1 (GLP ... GLP-1 agonists are ...

  10. Female infertility - Diagnosis & treatment - Mayo Clinic

    Determine alternatives — adoption, donor sperm or ... On average, how many days pass between the beginning of one menstrual cycle and the beginning of your next ...